Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,otherCurrentAssets,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,shortLongTermDebt,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,netReceivables,longTermDebt,inventory,accountsPayable,deferredLongTermLiab,changeToLiabilities,totalCashflowsFromInvestingActivities,netBorrowings,totalCashFromFinancingActivities,changeToOperatingActivities,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,depreciation,otherCashflowsFromInvestingActivities,otherCashflowsFromFinancingActivities,changeToNetincome,capitalExpenditures,issuanceOfStock,changeToInventory,changeToAccountReceivables,WC,language,region,quoteType,triggerable,quoteSourceName,regularMarketChangePercent,regularMarketDayRange,ask,bid,regularMarketPreviousClose,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,currency,marketState,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,market,priceHint,exchangeDataDelayedBy,twoHundredDayAverageChangePercent,shortName,exchange,epsTrailingTwelveMonths,epsForward,epsCurrentYear,priceEpsCurrentYear,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,marketCap,forwardPE,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,esgPopulated,tradeable,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (May 27, 2021) 4","Short Ratio (May 27, 2021) 4","Short % of Float (May 27, 2021) 4","Short % of Shares Outstanding (May 27, 2021) 4","Shares Short (prior month Apr 29, 2021) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,compensationRisk,auditRisk,longBusinessSummary,city,phone,state,shareHolderRightsRisk,compensationAsOfEpochDate,governanceEpochDate,boardRisk,country,website,maxAge,overallRisk,address1,industry
t0,ELAN,-4041000000.0,472800000,89000000,,-80000000,,-61000000,346000000,673000000,91000000,91000000,,-61000000,,,,-19000000,1242000000,1151000000,569000000,-171000000,,-61000000,-61000000,6032000000.0,8647000000.0,8981000000.0,8007000000.0,573000000.0,16988000000.0,22000000.0,-538000000.0,1368000000.0,6016000000.0,-102000000.0,291000000.0,515000000.0,2034000000.0,605000000.0,-102000000.0,1271000000.0,3344000000.0,34000000.0,1132000000.0,5579000000.0,1424000000.0,411000000.0,,0.0,10000000.0,30000000.0,2000000.0,-183000000.0,9000000.0,-25000000.0,22000000.0,202000000.0,-7000000.0,-28000000.0,64000000.0,-18000000.0,,,,1310000000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,-0.119834974,33.1 - 33.42,33.39,33.37,33.38,10,8,finmb_576158911,NYSE,Elanco Animal Health Incorporated,USD,3828892,3131433,7.58,0.29425466,25.76 - 37.49,-4.1500015,-0.11069622,25.76,37.49,1620390600,1636029000,1636374600,USD,REGULAR,33.34,1630508460,-0.040000916,33.28,33.42,33.1,378501,us_market,2,0,0.015254464,Elanco Animal Health Incorporat,NYQ,-1.27,1.31,1.0,33.34,17.96,33.775276,-0.43527603,-0.0128874155,32.839058,0.50094223,15763151872,25.450382,1.8563476,15,America/New_York,EDT,-14400000,False,False,0.85,,,37.49,25.76,33.78,32.84,3.83M,3.13M,472.8M,,425.55M,4.20%,101.97%,8.58M,2.44,1.93%,1.81%,9.58M,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",-14.83%,2.03%,0.37%,-7.80%,3.86B,8.35,88.80%,1.7B,680.2M,-572.1M,-1.27,,515M,1.09,6.18B,77.23,1.64,17.96,-23M,126.59M,Value,46140,Healthcare,10200,2,2,"Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as functional nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations in approximately 90 countries in North America, Europe, the Middle East, Africa, Latin America, and the Asia-Pacific. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.",Greenfield,877 352 6261,IN,9,1609372800,1622505600,7,United States,http://www.elanco.com,86400,5,2500 Innovation Way,Drug Manufacturers—Specialty & Generic
t-1,ELAN,-4136200000.0,472800000,112700000,,-318100000,,-322800000,374100000,600500000,-50000000,-50000000,,-60400000,,,,4700000,1139700000,1189700000,539200000,-268100000,,-322800000,-322800000,6387300000.0,8650100000.0,9216800000.0,8475900000.0,549600000.0,17692700000.0,46500000.0,-477200000.0,1340900000.0,6224800000.0,303000000.0,127300000.0,494700000.0,2076300000.0,554500000.0,303000000.0,1503400000.0,3416500000.0,33400000.0,1076700000.0,5648200000.0,1578100000.0,501000000.0,,369300000.0,-73300000.0,-17300000.0,-18300000.0,-413800000.0,-165200000.0,19300000.0,-92900000.0,187200000.0,900000.0,-19400000.0,132900000.0,-118400000.0,18400000.0,-94700000.0,14000000.0,1340200000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,-0.119834974,33.1 - 33.42,33.39,33.37,33.38,10,8,finmb_576158911,NYSE,Elanco Animal Health Incorporated,USD,3828892,3131433,7.58,0.29425466,25.76 - 37.49,-4.1500015,-0.11069622,25.76,37.49,1620390600,1636029000,1636374600,USD,REGULAR,33.34,1630508460,-0.040000916,33.28,33.42,33.1,378501,us_market,2,0,0.015254464,Elanco Animal Health Incorporat,NYQ,-1.27,1.31,1.0,33.34,17.96,33.775276,-0.43527603,-0.0128874155,32.839058,0.50094223,15763151872,25.450382,1.8563476,15,America/New_York,EDT,-14400000,False,False,0.85,,,37.49,25.76,33.78,32.84,3.83M,3.13M,472.8M,,425.55M,4.20%,101.97%,8.58M,2.44,1.93%,1.81%,9.58M,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",-14.83%,2.03%,0.37%,-7.80%,3.86B,8.35,88.80%,1.7B,680.2M,-572.1M,-1.27,,515M,1.09,6.18B,77.23,1.64,17.96,-23M,126.59M,Value,46140,Healthcare,10200,2,2,"Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as functional nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations in approximately 90 countries in North America, Europe, the Middle East, Africa, Latin America, and the Asia-Pacific. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.",Greenfield,877 352 6261,IN,9,1609372800,1622505600,7,United States,http://www.elanco.com,86400,5,2500 Innovation Way,Drug Manufacturers—Specialty & Generic
t-2,ELAN,-3876100000.0,472800000,88100000,,-209000000,,-135000000,277700000,480900000,19500000,19500000,,-48100000,,,,-74000000,889600000,870100000,408700000,-228500000,,-135000000,-135000000,5785600000.0,8620400000.0,8892800000.0,8344200000.0,544300000.0,17237000000.0,21400000.0,-154400000.0,1260300000.0,6434700000.0,-121800000.0,443300000.0,659900000.0,1871200000.0,553600000.0,-121800000.0,1270300000.0,3281400000.0,21700000.0,833100000.0,5673500000.0,1597100000.0,355900000.0,,0.0,-4696900000.0,4168600000.0,4068300000.0,85200000.0,-731200000.0,9100000.0,-111700000.0,132300000.0,-6700000.0,-100300000.0,-194200000.0,-16200000.0,18400000.0,-94700000.0,14000000.0,1410200000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,-0.119834974,33.1 - 33.42,33.39,33.37,33.38,10,8,finmb_576158911,NYSE,Elanco Animal Health Incorporated,USD,3828892,3131433,7.58,0.29425466,25.76 - 37.49,-4.1500015,-0.11069622,25.76,37.49,1620390600,1636029000,1636374600,USD,REGULAR,33.34,1630508460,-0.040000916,33.28,33.42,33.1,378501,us_market,2,0,0.015254464,Elanco Animal Health Incorporat,NYQ,-1.27,1.31,1.0,33.34,17.96,33.775276,-0.43527603,-0.0128874155,32.839058,0.50094223,15763151872,25.450382,1.8563476,15,America/New_York,EDT,-14400000,False,False,0.85,,,37.49,25.76,33.78,32.84,3.83M,3.13M,472.8M,,425.55M,4.20%,101.97%,8.58M,2.44,1.93%,1.81%,9.58M,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",-14.83%,2.03%,0.37%,-7.80%,3.86B,8.35,88.80%,1.7B,680.2M,-572.1M,-1.27,,515M,1.09,6.18B,77.23,1.64,17.96,-23M,126.59M,Value,46140,Healthcare,10200,2,2,"Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as functional nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations in approximately 90 countries in North America, Europe, the Middle East, Africa, Latin America, and the Asia-Pacific. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.",Greenfield,877 352 6261,IN,9,1609372800,1622505600,7,United States,http://www.elanco.com,86400,5,2500 Innovation Way,Drug Manufacturers—Specialty & Generic
t-3,ELAN,1175200000.0,472800000,59400000,,-77100000,,-53200000,162800000,290400000,19200000,19200000,,-24800000,,,,-23900000,586300000,567100000,295900000,-96300000,,-53200000,-53200000,2432700000.0,6886100000.0,3224100000.0,6651900000.0,334900000.0,9876000000.0,25300000.0,-19400000.0,253200000.0,3044000000.0,-214800000.0,236500000.0,1391100000.0,835400000.0,25900000.0,-214800000.0,951900000.0,3191300000.0,19600000.0,616800000.0,2107700000.0,1065300000.0,242500000.0,27300000.0,0.0,10600000.0,-6400000.0,7300000.0,215500000.0,184700000.0,7500000.0,159300000.0,80900000.0,6600000.0,13700000.0,-83900000.0,12600000.0,18400000.0,-94700000.0,14000000.0,2355900000.0,en-US,US,EQUITY,True,Nasdaq Real Time Price,-0.119834974,33.1 - 33.42,33.39,33.37,33.38,10,8,finmb_576158911,NYSE,Elanco Animal Health Incorporated,USD,3828892,3131433,7.58,0.29425466,25.76 - 37.49,-4.1500015,-0.11069622,25.76,37.49,1620390600,1636029000,1636374600,USD,REGULAR,33.34,1630508460,-0.040000916,33.28,33.42,33.1,378501,us_market,2,0,0.015254464,Elanco Animal Health Incorporat,NYQ,-1.27,1.31,1.0,33.34,17.96,33.775276,-0.43527603,-0.0128874155,32.839058,0.50094223,15763151872,25.450382,1.8563476,15,America/New_York,EDT,-14400000,False,False,0.85,,,37.49,25.76,33.78,32.84,3.83M,3.13M,472.8M,,425.55M,4.20%,101.97%,8.58M,2.44,1.93%,1.81%,9.58M,,,,,,0.00%,,,,,"Dec 30, 2020","Mar 30, 2021",-14.83%,2.03%,0.37%,-7.80%,3.86B,8.35,88.80%,1.7B,680.2M,-572.1M,-1.27,,515M,1.09,6.18B,77.23,1.64,17.96,-23M,126.59M,Value,46140,Healthcare,10200,2,2,"Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as functional nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations in approximately 90 countries in North America, Europe, the Middle East, Africa, Latin America, and the Asia-Pacific. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.",Greenfield,877 352 6261,IN,9,1609372800,1622505600,7,United States,http://www.elanco.com,86400,5,2500 Innovation Way,Drug Manufacturers—Specialty & Generic
